Hahn, Noah M.;Chang, Sam S.;Meng, Maxwell;Shore, Neal D.;Konety, Badrinath R.;Steinberg, Gary D.;Gschwend, Juergen E.;Nishiyama, Hiroyuki;Redorta, Juan Palou;Taylor, John Arthur;Elegbe, Ayanbola;Lambert, Alexandre;Zhu, Li;Ishii, Yuko;Maeda, Toshiki;Raybold, Bradley;Grossfeld, Gary;Fischer, Bruce S.;Rutstein, Mark;Witjes, Alfred.A phase II, randomized study of nivolumab (nivo) or nivo plus BMS-986205 with or without intravesical Bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC): CheckMate 9UT..J Clin Oncol.2019.37 Suppl S.7